Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in Botswana

Journal of Infection(2023)10.1016/j.jinf.2023.02.037Source: DataRank Database

Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in Botswana is a research paper published in Journal of Infection (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.17)OA: bronzeTopics (42)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (27)

Alane Izu ORCID,Tendani Gaolathe,Adam K. Walker ORCID,Lucy Carty ORCID,Panayiotis Georgiou ORCID

Live enrichment

PubMed:36863535 PMC:PMC9974206 OpenAlex:https://openalex.org/W4322615466

Bill & Melinda Gates Foundation

Grant: INV-033558

Fogarty International Center

Grant: K43 TW012350-01

AstraZeneca PLC

Grant: D8111C00013/ESR-21\u201321311

AstraZeneca

Grant: D8111C00013/ESR-21–21311

FIC NIH HHS

Grant: K43 TW012350

National Institutes of Health

Grant: 1K43TW012350-01

Viral Diversity an Innovative Biomarker for Refining Estimates of HIV Incidence

FWCI

0.17

Citation Percentile

0.4%

Citation Trend

2023

bronzeLicense: Elsevier TDM

journalhttp://www.journalofinfection.com/article/S0163445323001238/pdf

publisherhttp://www.journalofinfection.com/article/S0163445323001238/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0163445323001238?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0163445323001238?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jinf.2023.02.037

Fields of Study

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research Studies0303 health sciences03 medical and health sciencesHumansChAdOx1 nCoV-19BotswanaIncidenceCOVID-19 VaccinesCOVID-19VaccinationAntibodies, Viral

MeSH Terms

COVID-19COVID-19 VaccinesChAdOx1 nCoV-19Antibodies, ViralBotswanaHumansVaccinationIncidence

Keywords

MedicineVaccinationImmunogenicityCoronavirus disease 2019 (COVID-19)ImmunosuppressionIncidence (geometry)PopulationInternal medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyImmune systemEnvironmental healthInfectious disease (medical specialty)BotswanaCOVID-19 VaccinesChAdOx1 nCoV-19IncidenceHumansCOVID-19Antibodies, ViralLetter to the Editor

Sustainable Development Goals

SDG 0: Good health and well-being